Connect with us

Lunesta (eszopiclone)

Eszopiclone (or LUNESTA®) is mainly prescribed to treat insomnia.

Status: ACTIVE

Class: Nonbenzodiazepine, Z-drug

FDA Approval: 2004

Dosage Forms: 1 mg, 2 mg, 3 mg

Biological Half-life: 6 hours

Side Effects: Sleepiness, dizziness, headache, dry mouth, itching, chest pain, unpleasant taste, hallucinations, confusion, depersonalization, frequent urination

Precautions: May trigger sleep walking, driving or eating; increase suicidal thoughts

Routes of Administration: Oral

Pregnancy Category: C (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.